Drug
Entecavir clinical trials
Also written Baraclude and BMS-200475.
Includes 1 study of Entecavir maleate.
- studies test it
- 106
- open now
- 6
- in phase 3
- 20
- first study started
- 2001
Keep track of what changes. Save the entecavir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Development codes
Studies by the year they started
106 studies that test it; most in 2008 (12)
| Year | Studies |
|---|---|
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 8 |
| 2008 | 12 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 7 |
| 2013 | 10 |
| 2014 | 5 |
| 2015 | 8 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 5 |
| 2025 | 2 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 19
- Phase 3
- 20
- Phase 4
- 52
- No phase
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 41 · Other 65
Bristol-Myers Squibb (24) · Sun Yat-sen University (6) · Yonsei University (5) · Hoffmann-La Roche (4) · Asan Medical Center (3) · Taipei Veterans General Hospital, Taiwan (3) · ShuGuang Hospital (3) · Nanfang Hospital, Southern Medical University (3)
Often tested with
Tested in the same studies.
Tenofovir (18) · Lamivudine (7) · Adefovir (7) · Peginterferon alfa-2a (4) · Tenofovir alafenamide (3) · Fuzheng huayu (3) · ARC-520 (2) · Tenofovir amibufenamide (1)
Studies
Open first, then newest update. How each study uses entecavir is read from its arms, and is right about nine times in ten.
Testing it · 106
- Comparison of Viral Suppression With 0.5 mg and 1.0 mg Daily Doses of Entecavir in Decompensated HBV Cirrhosis of LiverRecruitingPhase 4Bangladesh Medical UniversityNCT07816094Written as Entecavir
- Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis BRecruitingPhase 4Taichung Veterans General HospitalNCT03933384Written as Entecavir
- Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis BNot yet recruitingPhase 4Qing-Lei ZengNCT07345611Written as Entecavir
- Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis BNot yet recruitingPhase 4Qing-Lei ZengNCT07345624Written as Entecavir
- Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV DonorsRecruitingPhase 4University Health Network, TorontoNCT07189377Written as Entecavir
- Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B CarriersRecruitingPhase 3Sun Yat-sen UniversityNCT06966232Written as Entecavir
- Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir AmibufenamideCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07295873Written as Entecavir
- The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D InfectionCompletedPhase 1PharmaEssentiaNCT04638439Written as P1101 + Nivolumab + Entecavir
- Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)Active, not recruitingPhase 2Sun Yat-sen UniversityNCT05453435Written as Entecavir
- A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02065336Written as entecavir
- Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02738008Written as entecavir
- A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB SubjectsCompletedPhase 1Aligos TherapeuticsNCT04536337Written as Entecavir
- Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCCCompletedPhase 3Guangxi Medical UniversityNCT02650271Written as Entecavir
- A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical SettingCompletedPhase 1Bristol-Myers SquibbNCT03083821Written as Baraclude
- A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With EntecavirCompletedPhase 2Enyo PharmaNCT04365933Written as Entecavir
- The Renal Safety of Tenofovir Alafenamide in HBV-related Acute-on-chronic Liver Failure: Real-World StudyCompletedNot applicableXiangya Hospital of Central South UniversityNCT05453448Written as Entecavir
- RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative ResectionActive, not recruitingPhase 4West China HospitalNCT04032860Written as Entecavir
- Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc)Status unknownNot applicableThe University of Hong KongNCT04199819Written as entecavir
- Antiviral Therapy for Patients With Chronic Hepatitis B InfectionStatus unknownPhase 2Sun Yat-sen UniversityNCT05382351Written as Entecavir
- Metformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis BCompletedNot applicableFu-Sheng WangNCT04182321Written as Metformin & Entecavir
See all 106 studies that test entecavir →
Given in every arm · 59 — entecavir is usual care beside what is tested
- Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor ResponseNot yet recruitingPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07797231Written as Entecavir dispersible tablets
- ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus InfectionRecruitingPhase 4The Second Affiliated Hospital of Chongqing Medical UniversityNCT07573943Written as Nucleotide analogs
- A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis BRecruitingPhase 2Ascentage Pharma Group Inc.NCT04568265Written as Entecavir 0.5 mg
- Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study)CompletedPhase 2Tongji HospitalNCT04202653Written as ETV
- A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D VirusCompletedPhase 2Janssen Research & Development, LLCNCT04535544Written as Entecavir (ETV) monohydrate
- Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)TerminatedPhase 2Arrowhead PharmaceuticalsNCT02577029Written as entecavir
- A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02604212Written as entecavir
- A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02604199Written as entecavir
- A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)TerminatedPhase 1Arrowhead PharmaceuticalsNCT02797522Written as entecavir
- Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B VirusTerminatedPhase 2Arrowhead PharmaceuticalsNCT02452528Written as Entecavir
- A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected SubjectsWithdrawnPhase 2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06990776Written as Entecavir dispersible tablets
- A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus InfectionCompletedPhase 2Janssen Research & Development, LLCNCT04585789Written as Entecavir (ETV)
- An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B ParticipantsCompletedPhase 2Janssen Research & Development, LLCNCT05275023Written as Entecavir
- A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCompletedPhase 2Janssen Sciences Ireland UCNCT04129554Written as Entecavir (ETV) monohydrate
- A Single and Multiple Ascending Dose Study of JNJ-64457744TerminatedPhase 1Janssen Research & Development, LLCNCT05423106Written as Entecavir (ETV)
- A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) InfectionCompletedPhase 1Suzhou Ribo Life Science Co. Ltd.NCT05017116Written as Entecavir
- A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis BActive, not recruitingPhase 1/2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06150014Written as Entecavir dispersible tablets
- A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCompletedPhase 2Janssen Research & Development, LLCNCT04667104Written as Entecavir (ETV) monohydrate
- Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV InfectionCompletedPhase 2Sunshine Lake Pharma Co., Ltd.NCT04147208Written as ETV
- Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid TumorsTerminatedPhase 3SWOG Cancer Research NetworkNCT03887702Written as Entecavir
Showing 20 of 59.
As the comparator · 23 — what is tested is compared with entecavir
- Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOPRecruitingPhase 3Ou Bai, MD/PHDNCT07493109Written as Entecavir Tablets
- Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLFRecruitingNot applicableThird Affiliated Hospital, Sun Yat-Sen UniversityNCT03920618Written as Entecavir
- Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudyTerminatedPhase 1/2Sunshine Lake Pharma Co., Ltd.NCT04536532Written as entecavir tablets
- Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudyCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT05391360Written as entecavir tablets
- Finite Versus Continuous Nucleos(t)Ide Analogues for Chronic Hepatitis BActive, not recruitingNot applicableE-DA HospitalNCT05793268Written as Entecavir or Tenofovir
- Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue TherapyStatus unknownNot applicableNational Taiwan University HospitalNCT05494528Written as Entecavir
- A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative ResectionStatus unknownPhase 3Sun Yat-sen UniversityNCT04392700Written as Entecavir 0.5 mg
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated CirrhosisStatus unknownNot applicableThird Affiliated Hospital, Sun Yat-Sen UniversityNCT04196998Written as Entecavir
- PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B PatientsCompletedPhase 4Foundation for Liver ResearchNCT01373684Written as Nucleos(t)ide analogue
- Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis BCompletedPhase 1/2Hepatera Ltd.NCT02881008Written as Entecavir
- Evaluation of the Safety and Pharmacology of EYP001 in HBV SubjectsCompletedPhase 1Enyo PharmaNCT03272009Written as Entecavir
- Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis BCompletedPhase 4Asan Medical CenterNCT01639092Written as Entecavir
- Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis BCompletedPhase 3Asan Medical CenterNCT01595685Written as Entecavir
- Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid AnalogueCompletedPhase 3GlaxoSmithKlineNCT01480284Written as ETV 0.5 mg capsule
- A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHBStatus unknownPhase 1/2Third Affiliated Hospital, Sun Yat-Sen UniversityNCT02615639Written as Entecavir
- Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BCompletedPhase 3Novartis PharmaceuticalsNCT00412529Written as Entecavir
- A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV PatientsTerminatedPhase 4Bukwang PharmaceuticalNCT01266005Written as Entecavir
- Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNACompletedPhase 3Third Affiliated Hospital, Sun Yat-Sen UniversityNCT01892241Written as Entecavir
- Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BCompletedPhase 2LG Life SciencesNCT01026610Written as entecavir 0.5 mg
- Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg LossStatus unknownNot applicableSun Yat-sen UniversityNCT01599130Written as Entecavir
Showing 20 of 23.
Codes
What other systems call entecavir · ClinicalTrials.gg INT004266
- MeSH (NLM) C413685entecavirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5968Y6H45MENTECAVIRConfirmed FDA, NLM, Wikidata
- RxNorm 306266Confirmed FDA, Wikidata
- Wikidata Q27126952entecavir hydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65513EntecavirConfirmed FDA, Wikidata
- DrugBank DBSALT001748One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C413685 | entecavir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5968Y6H45M | ENTECAVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 306266 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27126952 | entecavir hydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65513 | Entecavir | Confirmed FDA, Wikidata |
| DrugBank | DBSALT001748 | — | One source Wikidata |
Also registered as entecavir anhydrous (UNII NNU2O4609D · RxNorm 1546027).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.